Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments

Treatment of FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML) remains a challenge despite the development of novel FLT3-directed tyrosine kinase inhibitors (TKI); the relapse rate is still high even after allogeneic stem cell transplantation....

Descripción completa

Detalles Bibliográficos
Autores principales: Scholl, Sebastian, Fleischmann, Maximilian, Schnetzke, Ulf, Heidel, Florian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697863/
https://www.ncbi.nlm.nih.gov/pubmed/33212779
http://dx.doi.org/10.3390/cells9112493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697863/
https://www.ncbi.nlm.nih.gov/pubmed/33212779
http://dx.doi.org/10.3390/cells9112493

Ejemplares similares